key: cord-0058906-l0hv0r4l
authors: Alokour, Mamoon; Yilmaz, Elvan
title: A polymer hybrid film based on poly(vinyl cinnamate) and poly(2-hydroxy ethyl methacrylate) for controlled flurbiprofen release
date: 2021-03-19
journal: J Polym Res
DOI: 10.1007/s10965-021-02493-2
sha: 7cd6c5f211050d058d6e9ea798f1447f9132d94c
doc_id: 58906
cord_uid: l0hv0r4l

A crosslinked polymer hybrid film, ipn-poly(vinyl cinnamate-graft-2-hydroxy ethyl methacrylate)-v-poly(ethylene glycol dimethacrylate) was synthesized by UV initiation using poly(vinyl cinnamate) (polyVCi), 2-hydroxy ethyl methacrylate (HEMA) monomer and ethylene glycol dimethacrylate (EGDMA) crosslinker. Benzophenone (Ph(2)CO), was used as the photoinitiator. The synthesis was optimized by changing the concentration of HEMA, Ph(2)CO, EGDMA, and UV irradiation time. PolyVCi undergoes photocrosslinking by 2 + 2 photocylo addition while the monomer/crosslinker couple, HEMA/EGDMA, undergoes free radical polymerization and crosslinking to form EGDMA crosslinked polyHEMA. Hence, simultaneous interpenetrating polymer network (IPN) formation occurs. The IPN consists of dual network of photocrosslinked polyVCi and EGDMA crosslinked polyHEMA chains. Grafting of HEMA/EGDMA chains on the polyVCi backbone also occur during network formation. The chemical functionalities present in the polyVCi/polyHEMA/polyEGDMA IPN films obtained were characterized by FTIR and SEM analysis. The contact angle measurements show enhanced wettability of the IPN film compared to polyVCi surface. TGA analysis confirms thermal stability of the films. Swelling behavior of the films examined in water and in ethanol reveals the effects of the chemical natures of polyVCi and polyHEMA as well as that of crosslinking on the hydrophilicity of the film. The films were tested as drug release matrices using flurbiprofen. The drug was loaded into the film matrix during IPN formation under UV irradiation. PolyVCi/polyHEMA/polyEGDMA IPN proved to be a suitable release matrix for flurbiprofen demonstrating controlled release behavior and zero-order release kinetics. The release mechanism was confirmed by its Ritger-Peppas “n” value (1.00 to 1.42), which indicates super case II release.

Nowadays, controlled drug release is receiving increasing attention due to the need for effective and safer drug formulations with reduced side effects. Unlike conventional drug delivery formulations, controlled drug delivery systems release the drug into the desired biological fluid at a slower and constant rate [1] . In such systems, the drug is generally entrapped or encapsulated within a polymer matrix. These systems target at controlling and sustaining the distribution of drugs to achieve optimal therapeutic efficiency [2] . Furthermore, designed drug release profiles improve the specific action of the drug at the required site and when needed. One example to designed drug delivery is pulsatile drug delivery systems, which are developed to deliver the drug according to circadian behavior of diseases. In other words, these systems will deliver drug at a certain time when the disease shows its most morbid and mortal state within a circadian cycle, 24 h. The product exhibits a sigmoidal drug release profile with no release known as lag time followed by a rapid and complete drug release. Thus, the drug can be delivered at the correct time, in the correct amount and at the right site of action using this approach [3] .

Chemical, physical and biological processes affect the rate of drug release from the dosage form. The properties of the drug such as polarity and solubility, type of the polymer and binding agents, preparation methods, and the administration route are important parameters that govern these processes [4] . Diffusion of active and inactive part of the dosage form, hydration of the dosage form, polymer swelling and degradation, pH changes, drug degradation, are some elements of the chemical and physical processes involved in drug release kinetics. Simultaneous occurrence of these elements complicates the design of the drug formulation. Usually, one of these processes occurs slower than others and determines the overall rate of drug release. Various mathematical models are available to follow the drug release kinetics from matrix systems. Most commonly studied models are zero-order, first-order, Higuchi and Korssmayer-Peppas models.

Each model is characterized by the corresponding equation given below [5] :

Zero order model:

where Q t is the amount of drug dissolved in time t, Q o is the initial amount of drug in solution, and K o is the rate constant of the release. First order model:

where C o is the initial concentration of drug, and K is first order release constant t is time.

Higuchi model:

where Q is the amount of drug released in time t per unit area, K H is Higuchi dissolution constant. Korssmayer-Peppas model:

where M t / M ∞ is a fraction of drug released at time t, k is the release rate constant, and n is the release exponent. An Interpenetrating Polymer Network (IPN) is a combination of two or more crosslinked polymers of different characteristics. It is synthesized when one polymer network is formed in the presence of the other either sequentially or simultaneously [6] . IPN's are useful as controlled release matrices as two polymer components of different nature may exist together forming a suitable medium to trigger drug release under different conditions. Some examples of IPN's with controlled drug release in the literature are as follows: The release behavior of bovine serum albumin (BSA) from silk sericin/poly(methacrylic acid), and silk sericin/

poly(N-isopropylacrylamide) IPN hydrogels [7] . A polyacrylamide grafted carrageenan and sodium alginate IPN was synthesized and represented a pH-responsive hydrogel used for targeting ketoprofen to the intestines [8] . Encapsulation and controlled release of diclofenac sodium was achieved in a smart macroporus IPN hydrogel that was synthesized sequentially by forming one network of poly(N,Ndimethylaminoethyl methacrylate) crosslinked with N,N′methylenebisacrylamide (BAAm) at -18℃, followed by the other network of polyacrylamide crosslinked with BAAm [9] . In this study, polyVCi/polyHEMA IPN films were synthesized and tested for loading and release of the nonsteroidal anti-inflammatory drug (NSAID) flurbiprofen. The study presented here forms a simple, chemical model system composed of the polymeric matrix and the drug only, which may serve as a basis for further development of advanced drug formulations. Flurbiprofen is used during eye surgery and for the treatment of rheumatoid arthritis, ankylosing spondylitis, and degenerative joint disease for the reduction of pain, fever and inflammation [10] . When administered orally, flurbiprofen, as many NSAIDs, is absorbed from the upper gastrointestinal tract and causes gastric irritation [11] . Flurbiprofen use may cause other discomforting side effects in addition to stomach and intestinal disorders. Some of these are dizziness, drowsiness or allergic reactions such as itching and skin rush. Patients with rheumatoid arthritis that is characterized by joint pain and functional disability symptoms experience the symptoms of the disease most severely during early morning hours. The discomfort is experienced for long periods of time that pushes the tolerance limits of the patients. Hence, designing a time-controlled drug delivery system which could supply the therapeutic drug dosage at predetermined time intervals in a pulsatile manner is anticipated to improve patience compliance to the drug considerably as this would allow less frequent drug administration with reduced side effects. The polyVCi/polyHEMA/ polyEGDMA IPN films used in this study proved to fulfill this aim demonstrating controlled flurbiprofen release with lag time behavior.

The IPN polymer matrix synthesized is composed of polyVCi crosslinked network formed by 2 + 2 photocylo addition under UV irradiation and polyHEMA crosslinked with EGDMA. Both networks were formed at the same time and under the same conditions. The hybrid polymer gel system composed of a dual network of photocrosslinked polyVCi and EGDMA crosslinked polyHEMA has not been reported in the literature before and is denoted as ipnpoly(vinyl cinnamate-graft-2-hydroxy ethyl methacrylate)v-poly(ethylene glycol dimethacrylate). Investigation of the physicochemical properties of the products proved achievement of a compromise between the more hydrophilic nature of polyHEMA and the hydrophobic nature of polyVCi polymer. The first component of the system, vinyl cinnamate (VCi), and especially its copolymers are well known for their photo responsive behavior including photo initiated polymerization, photo crosslinking [12] , and light induced bending of its gels [13] . Cinnamoyl groups undergo 2 + 2 photocylo addition to form crosslinked gels under UV light. Photo responsive hydrogels/nanogels of polyVCi can undergo UV induced bending or volume transition [14] , which may find use in phototherapy, as drug carriers, or in medical imaging in addition to application in optoelectronics. PolyVCi and its copolymers with hydrophilic polymers can form micelles in solution and molecular arrangement leading to liquid crystal behavior [15] . Studies on either homopolymerization [16, 17] or copolymerization of VCi or on its blends and composites are scarce in the literature. Various poly(vinylalcohol-co-vinylcinnamate) derivatives including poly(vinylalcohol-co-vinylcinnamate), poly(vinylalcohol-co-vinyl-4-methoxycinnamate), poly(vinylalcohol-co-vinyl-2,4-di methoxy cinnamate) and poly(vinylalcohol-co-vinyl-2,4,5-trimethoxycinnamate) were synthesized by grafting poly(vinylalcohol) with appropriate cinnamoyl groups. Amphiphilic block or graft copolymers containing hydrophilic and hydrophobic segments have the ability of micelle formation by self-assembly in selective solvents [18] . Many blends and composites of polyVCi had been reported in the literature [19] [20] [21] . Poly(2-hydroxy ethyl methacrylate) (polyHEMA), on the other hand, has been proven to be a useful polymer for applications in the biomedical field since it was first synthesized in 1960. These applications include the use of polyHEMA in the fields of contact lenses, artificial corneas and skins, drug delivery, and degradable scaffolds for tissue engineering [22] . PolyHEMA hydrogels are versatile materials due to their non-toxicity, biocompatibility, and thermal stability [23] .

Herein, optimum synthesis conditions for simultaneous IPN formation between polyVCi and polyHEMA is reported. The products have been characterized with respect to their chemical structures, chemical compositions, and physical properties such as surface morphology and thermal properties in addition to their swelling kinetics. The swelling characteristics and the contact angle measurements demonstrated modified hydrophilicity/hydrophobicity of the IPN formed with respect to individual polyVCi and polyHEMA. FTIR gave evidence with respect to the chemical structure of the products. TGA confirmed thermal stability up to 300 °C, and SEM analysis enlighten the morphology. The product films proved to be suitable loading and release systems for flurbiprofen providing controlled drug release behavior. The synthesized polymeric release matrix is novel and exemplifies a hybrid polymeric system composed of polymers with hydrophilic/hydrophobic nature and suitable morphology giving rise to controlled release behavior for flurbiprofen with a two-step release profile separated by a lag time mimicking pulsatile release behavior.

HEMA (Aldrich), and EGDMA (Aldrich) were cleaned from inhibitor by passing through inhibitor removal column (Aldrich). Flurbiprofen was provided by Pharma Mondial, North Cyprus. PolyVCi (Aldrich) was purified before use as described below. Benzophenone (Aldrich), chloroform (Aldrich), ethanol (Aldrich), methanol (Aldrich), tetrahydrofuran (THF) (Aldrich), and n-hexane (Aldrich) were used as received.

PolyVCi was cleaned from any poly(vinyl alcohol) impurity as follows: 0.5 g of polyVCi (Aldrich) was dissolved in 10.0 mL of chloroform. The solution was refluxed at 50 °C in an oil bath for 24 h. Then the flask was cooled down, and 30.0 mL of n-hexane was added to precipitate polyVCi. The suspension was stirred overnight, filtered and dried at 60 °C.

Purified PolyVCi was dissolved in THF to obtain a 5.0 g/L solution. Then different amounts of HEMA monomer (20.6, 41.2, 82.5, 123.8 mM), the crosslinker EGDMA (13.2, 26.5, 52.9 mM), and the photoinitiator (Ph 2 CO), (6.86, 13.7, 27.4 mM), were added to the polymerization solution, closed, and connected to N 2 gas bubbling system at room temperature for 20 min. The values given in parentheses are the concentrations of each species, namely HEMA, EGDMA and Ph 2 CO in the initial polymerization medium. The reaction was carried out at different time intervals. PolyVCi film was prepared for comparison of physicochemical properties with those of the IPN films. The reaction conditions are shown in Table 1 .

The homogeneous solutions (20 mL) were transferred into glass petri dishes and exposed to UV-irradiation using a Luzchem photoreactor LZC 4 V equipped with 6 top and 8 side UVA lamps of 350 nm wavelength and 7670 µW.cm −2 power. All samples were placed 15.0 cm distance from the lamps. Film samples were obtained after UV irradiation. The samples were taken from the chamber at given time intervals, soaked in ethanol for 2 days during which ethanol was refreshed regularly every 6 h. Then, the films were dried at room temperature, to constant weight. The films were insoluble in aqueous media, or in organic solvents. The product yield was calculated according to Eq. (5).

where: w p , w HEMA andw EGDMA stand for the weight of the product, initial weight of polyVCi, initial weight of HEMA and initial weight of EGDMA respectively, except for sample M, in which no EGDMA was added.

The gel content of the samples represented in Table 1 as M, B, D, E, and H films was measured by placing them into ethanol solvent for 48 h to ensure dissolution of all unreacted and/or soluble components. They were then dried at 50 °C for about 12 h to constant weight. The gel percent was calculated by using Eq. (6) given below.

where: Wd is the weight of dried insoluble film and Wi is the initial weight of dried sample.

Known masses of films were placed in water and in ethanol. The weight of the swollen sample was measured at several time intervals after excess surface water or ethanol was removed. The procedure was repeated until there was no further weight increase. The swelling percent was calculated in terms of the amount of absorbed water or ethanol by using Eq. (7) given below. The results reported are average values of three measurements for each sample.

where: W d is the initial weight of dried film, and W s is the final weight of the swollen film after a certain period of time.

PolyVCi was dissolved in THF to obtain a 5.0 g/L solution. Then a 41.2 mM of HEMA monomer, 26.5 mM of EGDMA, 13.7 mM of Ph 2 CO, and FB (20.5 or 10.25 mM) were added to the polymerization solution and closed, and connected to N 2 gas bubbling at room temperature for 20 min.. The homogeneous solutions (20 mL) were transferred into glass petri dishes and exposed to UV irradiation using a Luzchem photoreactor LZC 4 V equipped with 6 top and 8 side UVA lamps of 350 nm wavelength and 7670 µW.cm-2 power. The reaction was carried out for 8 h. Both samples were placed 15.0 cm distance from the lamps. Loaded films were obtained after UV irradiation, washed with ethanol several times, and dried at room temperature. The obtained films were labeled as FB 1 and FB 2 according to the initial concentration of the added drug; FB 1 stands for 10.25 mM of the drug, and when the initial concentration of drug is 20.5 mM the film obtained is labeled as FB 2 .

Loaded films (FB 1 and FB 2 ) were soaked in 100-mL of ethanol at room temperature. Aliquot volume of 1.0 mL of solution was drawn from the release medium at several given time intervals, and was measured using a (UV_Win 5.0, Bejjing, T80 +) UV/vis spectrometer at 249 nm. Three repeated measurements were performed each time for data validation. After each draw, the release medium was [10, 24] where M T is the amount of drug released from loaded films (FB 1 , FB 2 ) at time t, and M ∞ is the amount of drug released from the loaded films at time infinity taken as 48 h.

FTIR-ATR analysis of the films was made by using Perkin-Elmer Spectrum Two FTIR-ATR spectrometer.

Thermal Gravimetric Analysis (TGA) of the films was made using Perkin Elmer Diamond Differential Calorimeter and Perkin Elmer Pyris 1 under nitrogen atmosphere at 10 °C/ min heating rate in Central Laboratory of Middle East Technical University, Ankara.

Scanning Electron micrographs (SEM) of the films were taken in Central Laboratory of Middle East Technical University, Ankara using Quanta 400F field emission scanning electron microscope using Au-Pd coating.

The original polyVCi sample as provided by the producer and purified polyVCi were characterized by GPC in Middle East Technical University Central Laboratory using Malvern-OmniSEC instrument. The solvent was THF and the flow rate was set as 1 mL/min.

Optical contact angle measurements on the films were made using Attension Theta goniometer in in Central Laboratory of Middle East Technical University, Ankara, Turkey.

PolyVCi (Aldrich) was employed in IPN formation after purification as described above. The sample was found to have number average molecular weight of 9.20 × 10 4 g/mol and weight average molecular weight of 1.74 × 10 5 by SEC analysis. IPN formation was carried out by photoinitiation at 350 nm by simultaneous photocrosslinking of polyVCi polymer backbone and formation of EGDMA crosslinked polyHEMA. The samples isolated after ethanol treatment are crosslinked gels. The synthesis route and a schematic representation of the crosslinked hybrid system formed are given in Fig. 1 . This is a simultaneous IPN formation system, which is composed of three elements: (1) photocrosslinking of polyVCi chains via [2 + 2] cycloaddition mechanism, (2) formation of polyHEMA by free radical polymerization of HEMA and crosslinking of polyHEMA in the presence of EGDMA crosslinker (3) possible photoinitiated grafting of polyHEMA and polyEGDMA from polyVCi chains via active centers that are created on the polyVCi backbone. Altogether these entities form the IPN gel. A schematic representation of the IPN gel formed is given in Fig. 1 .

The IPN synthesis conditions were optimized with respect to initiator concentration, monomer and crosslinker concentrations and with respect to time. The synthesis conditions and the Yield % values are shown in Table 1 . The concentration of polyVCi solution was set as 5.0 g/L in all experiments. A blank sample of photocrosslinked polyVCi film (polyVCi) was prepared to establish any mass changes during photocrosslinking. No loss or gain in mass was observed after photocrosslinking of polyVCi. Studying the effect of Ph 2 CO concentration on the Yield %, Fig. 2a , revealed that increasing concentration of Ph 2 CO from 6.86 mM to 13.7 mM, results in an increase in Yield% value from 49.4% to 67.9%, due to higher number of active sites created in the reaction medium hence higher grafting possibility of polyHEMA onto the polyVCi backbone together with more polyHEMA chains initiated in the medium forming the EGDMA crosslinked polyHEMA network. Further increase in the Ph 2 CO concentration to 27.4 mM causes a slight decrease in Yield % to 60.9%. This effect can be an indication of radical-radical combination, which can lead to a decrease in initiator efficiency. Besides, as the initiator concentration increases, the number of short chain homopolymer molecules of HEMA increases, which are easily removed during the washing treatment. Since a decreasing trend was observed above 27.4 mM, no higher concentrations of the photoinitiator were tested. Since 13.7 mM Ph 2 CO gave the highest Yield % value as 67.9% (sample B), in all other experiments Ph 2 CO was used as 13.7 mM.

The effect of EGDMA concentration on the Yield % is shown in Fig. 2b . The synthesized IPN in the absence of EGDMA, sample M in Table 1 , gave 67.4% Yield value using 41.2 mM HEMA, and 13.7 mM Ph 2 CO after 4 h UV irradiation. Sample D prepared under the same conditions as sample M, but by adding 13.2 mM EGDMA to the system resulted in 80.6% Yield value providing gravimetric evidence for inclusion of EGDMA in the chemical structure. When more EGDMA are added during the IPN synthesis, as exemplified by sample B (26.5 mM EGDMA), and sample E (52.9 mM EGDMA), a decrease trend in the Yield % was observed. This behavior may be attributed to more homopolymerization of EGDMA, causing decreasing of crosslinking efficiency of EGDMA towards polyHEMA network. Less Yield % was achieved as polyEGDMA chains formed are washed away during purification of the product. Less powerful crosslinking efficiency of EGDMA with increasing concentration can be followed from the Gel Content values of the products as well. For M, D, B, and E films the Gel Content does not increase significantly but shows only a slight increase with EGDMA concentration with a tendency to level off as revealed by 61.4, 62.2, 65.5, and 67.1% Gel Content values respectively for M, D, B and E films. Figure 2c indicates that, as the HEMA concentration increases, the Yield% decreases. This may refer to more uncrosslinked polyHEMA formed, less polyHEMA grafted onto polyVCi backbone or less contribution of EGDMA crosslinked polyHEMA in the network formation. Since uncrosslinked homopolymer chains of polyHEMA can be easily removed through ethanol extraction the Yield% decreases.

Increasing irradiation time from 4 to 8 and to 12 h, increases the Yield % from 67.9% (sample B) to 70.2% (sample H) and to 84.3% (sample I) respectively. While the THF solvent is evaporated by time, the medium shifts to a bulk environment. As a result, termination reactions predominate over propagation reactions producing a significant increase in the amount of Yield% (sample I). On the other hand, 16 h irradiation time (sample Z) leads to lower Yield % value found as 54.2% (Fig. 2d ) due to chain degradation at prolonged irradiation times causing formation of low molecular weight chains that are washed away with ethanol.

The optical pictures of polyVCi, M, B, G, F, and I film samples are shown in Fig. 3 . Homogeneous, transparent films of average film thickness 10 µm were obtained. 

The gel contents of M, B, D, E, and H films were calculated, and the results reveal that by increasing the initial amount of EGDMA (M, D, B, and E films) the gel content increases only slightly with a tendency to level off as represented by Gel Content values of 61.4, 62.2, 65.5, and 67.1% respectively. On the other hand, by increasing the UV irradiation (H film) the gel content increases up to 79.4%, which indicates the formation of product of higher crosslinking density in time.

Swelling characteristics of the films are an important parameter to be evaluated for their application as drug loading and release media. Swelling kinetics of the films was followed in distilled water and in ethanol. The results reported are average values of three measurements for each sample using Microsoft Excel in order to calculate both mean and standard deviation. Figure 4a shows the swelling behavior of the films in distilled water. All samples reach equilibrium swelling within an hour. Sample M, which is resulting in lower crosslinking density and more hydrophilicity due to higher fraction of HEMA in the medium. Sample I (Yield% = 84.3%) that has been exposed to UV irradiation for 12 h, bears smaller equilibrium swelling capacity (56%) than the others showing that longer exposure to UV light increases the crosslinking density leading to smaller degree of swelling. It is interesting to note that the equilibrium swelling capacity of photocrosslinked polyVCi is unexpectedly high (307%) and comparable to those of IPN samples even though polyVCi alone is more hydrophobic than polyVCi/polyHEMA/poly-EGDMA based IPN samples. This behavior should be due to the macroporous morphology of the polyVCi sample as revealed by SEM analysis discussed below. Figure 4b shows that the maximum % swelling values in ethanol are higher compared to the values in water. This may be attributed to lower polarity of ethanol than water, which allows more favorable interactions with the hydrophobic polyVCi backbone in addition to favorable interactions of polyHEMA with ethanol. It is interesting to note that polyVCi film alone exhibits the highest swelling capacity in ethanol with 907% equilibrium swelling capacity. Porous nature of the polyVCi film together with favorable interactions with ethanol should be responsible from this behavior. When sample F is compared to B or G, it can be followed from Fig. 4b that they bear comparable equilibrium swelling capacity values. This must be due to comparable interaction abilities of the cinnamate and ethyl methacrylate moieties with ethanol. On the other hand, increasing the UV exposure time causes a decrease in the equilibrium % swelling values, due to higher crosslinking density, the same trend as was observed in water. The equilibrium swelling capacity of sample I prepared under 12 h UV exposure reduces to 175% in ethanol. Figure 5a shows the FTIR spectrum of polyVCi film. An absorption band at 1638 cm −1 corresponds to exocyclic C = C stretching of cinnamate moieties [25] . The C-O-C stretching vibration of polyVCi exhibits itself at 1164 cm −1 . Aromatic C-C and C-H stretching are observed at 703 and 766 cm −1 respectively. C = O stretching of unsaturated ester can be observed at 1710 cm −1 [26] .

Two characteristic peaks of polyHEMA (Fig. 5b) are at 3400 cm −1 and 1720 cm −1 corresponding to hydroxyl (OH) and carbonyl (C = O) stretching vibration bands, respectively [27] . The C-O-C band is observed at 1160 cm −1 . The C-O stretching of the primary alcohol of HEMA is observable at 1071 cm −1 . In Fig. 5c , the FTIR spectrum of polyVCi/polyHEMA IPN is given. The carbonyl stretching band of the copolymer is observed at 1724 cm −1 . The alkene functionality of polyVCi decreases due to the photocrosslinking as can be followed from the smaller C = C stretching band at 1638 cm −1 compared to that of polyVCi. The C-O-C stretching band is found at 1160 cm −1 . The C-O band of the alcohol group of HEMA is at 1076 cm −1 . Figure 5d that belongs to sample B, an EGDMA crosslinked polyVCi/polyHEMA sample is characterized Besides these characteristic bands, the overlap of EGDMA, polyVCi and poly-HEMA C-O-C bands in the region of 1000-1200 cm −1 is represented by a broader band for C-O-C stretching at 1151 cm −1 . Furthermore, the peak intensity of C = C stretching vibration at 1638 cm −1 has decreased due to photocrosslinking.

All of these characteristics provide evidence for successful IPN formation between polyVCi and polyHEMA.

FTIR of the drug loaded film (Fig. 5e) shows a characteristic peak at 1218 cm −1 which refers to C-F bond of flurbiprofen. This indicates successful encapsulation of the drug into the IPN. On the other hand, the disappearance of C-F bond in (Fig. 5f ) provides data in favor of efficient release of the drug.

Thermal behaviors of the samples have been recorded by thermal gravimetric analysis to provide evidence for thermal stabilities of the samples for future applications. For example, durability to heat sterilization is a requirement for biomedical devices. Figure 6a shows the TGA thermogram of polyVCi. The first decomposition peak is observed at 180 °C with around 45% weight loss, while the main mass loss occurs at a temperature around 330 °C. These observations indicate that the cinnamate groups are mainly broken from the main chain at 330 °C, and the detached cinnamates groups are evaporated, resulting in the weight loss [12, 28] . For polyHEMA (Fig. 6b) the decomposition takes place in three stages. In the first stage, around 7% weight loss occurs at 180 °C. The second stage and third stages where the main weight loss is observed are in the range of 300-400 °C. The first peak is at 300 °C and refers to the decomposition of C-O backbone, while the peak at 370 °C, can be presumed as the decomposition of the methacrylate component. Figure 6c shows the thermogram of the film M that has been prepared in the absence of the crosslinker EGDMA. It has two decomposition peaks. The first one appears at 120 °C with 30% weight loss, which refers to water loss. On the other hand, the main decomposition is peak observed at 330 °C, a small amount of polyHEMA incorporated in the polymer matrix does not affect the thermal behavior of polyVCi. For sample B (Fig. 6d ) two main decomposition peaks at 330 and 400 °C are clear evidence for the presence of EGDMA crosslinked polyHEMA in the IPN. The first peak at 300 °C belongs to the decomposition of the polyVCi backbone, while the second decomposition peak that shifts to a higher temperature (400 °C) than that of polyHEMA is a clear evidence for EGDMA crosslinking. For both films G and I (Fig. 6e and f) similar thermal stability has been observed as for film B. Figure 7 shows the surface morphology of polyVCi film and polyVCi/polyHEMA/polyEGDMA IPN films. The surface of polyVCi film shown in Fig. 7a , exhibits regular pores. The pore size as measured from the SEM picture is of the order of 1-2 microns. The formation of pores has been attributed to the evaporation of THF solvent during the photopolymerization, in other words THF acts as porogen. The surfaces of the IPN films exhibit heterogeneity on a continuous phase which reveals formation of interpenetrating network of two crosslinked polymers with different chemical nature. (Fig. 7b-d) . When films B (4 h UV irradiation) and H (8 h UV irradiation) are compared to each other, the effect of more UV irradiation on the morphology can be followed. Film H exhibits larger islands on the continuous phase providing evidence for higher crosslinking of polyHEMA in time via EGDMA incorporation into the system. Film G, on the other hand, bears a more homogenous surface that can be attributed to less crosslinking due to higher HEMA concentration in the polymerization in the medium compared to samples B and H.

Contact angle is a useful tool to estimate the hydrophilicity of the polymer films. The data presented below provide evidence for surface modification of polyVCi via hybridization with polyHEMA. It also gives a clue on the expected compatibility of the film with other hydrophilic surfaces, biomolecules or drugs. Figure 8 shows that the surface of the IPN formed is more hydrophilic than that of polyVCi. The contact angle of IPN film decreases from 77.23° to 64.11° (sample B) ( Fig. 8a and b) . Film I (Fig. 8c) shows more hydrophilicity than polyVCi, but less than that of B film with a contact angle of 70° due to more hydrophobicity imparted by more EGDMA crosslinking in time (12 h).

Flurbiprofen (Fig. 9 ) was loaded into polyVCi/polyHEMA/ polyEGDMA matrix during IPN formation. Two film samples loaded with flurbiprofen FB 1 and FB 2 were used in the release study. The amount of flurbiprofen encapsulated into the film was assumed to be the same as the amount of drug released from the loaded films at time infinity (M ∞ ). These values are 36.5 mg and 43.6 mg FB 1 and FB 2 respectively. Accordingly, the encapsulation efficiency of FB 1 and FB 2 has been calculated as 73.0% and 43.6% respectively.

As can be observed from Fig. 10a , flurbiprofen release from FB 1 shows a two-step release profile with an initial pulse within first 5 h demonstrating 32% cumulative release. This is followed by no release for a period of 15 h that can be identified as lag time period. After the lag time period, the drug is released with a second pulse, which is a release period that begins at 20 h and is completed at 35 h. A similar behavior has been observed for FB 2 film, except that the total release during the first release stage, within the first 5 h, is 22% (Fig. 10b) . In both cases, it is clear that a time controlled flurbiprofen release system is obtained by loading the drug into polyVCi/polyHEMA/polyEGDMA films. Two factors can be considered to explain the lag time behavior. These are the nature of the drug-matrix interaction and the morphology of the polyVCi/polyHEMA/poly-EGDMA matrix. Carbonyl functionalities available both on polyHEMA and polyVCi interact with flurbiprofen molecule via dipole-dipole interactions. Secondary interactions such as dispersion forces and dipole-dipole interactions are also available between benzene rings that exist in both polyVCi and flurbiprofen. Flurbiprofen, and polyHEMA component of the matrix may interact via hydrogen bonding interaction between the -OH groups available on both molecules or via strong dipole-dipole interaction between the fluorine atom and the hydroxyl group. So, it may be concluded that there are stronger favorable interactions between polyHEMA component of the copolymer than between polyVCi and flurbiprofen. Furthermore, polyVCi/polyHEMA/polyEGDMA films show two phase morphology as can be observed in the SEM pictures given in Fig. 7 . Two types of crosslinked regions are available in the matrix: the polyVCi network and EGDMA crosslinked polyHEMA network. The islands embedded in the continuous polyVCi matrix have been attributed to the EGDMA crosslinked polyHEMA regions within the IPN matrix. Flurbiprofen is distributed randomly in the IPN matrix during the photo encapsulation process. Hence, diffusion rate of the flurbiprofen molecule through these two different regions with different chemical nature and crosslinking density should be different resulting in the two-stage release behavior.

To understand the mechanism and kinetics of drug release, the results obtained were studied for two periods of release separately. The first one was from (time 0-5) h and denoted by PI, while the second period, PII, was used for the second release (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) h. The data were fit into different kinetic equations such as: zero order model (Eq. 1) Fig. 9 Flurbiprofen release profile from a FB 1 , b FB 2 films (mean ± SD, n = 3) (plotting cumulative % drug released versus time), first order (Eq. 2) (plotting log cumulative % drug remained versus time), Higuchi (Eq. 3) (plotting cumulative % released versus √time), and Korsmeyer Peppas (Eq. 4) (plotting log of cumulative % drug released versus log time, where the slope represents the n value). The kinetic model that best fits the dissolution data was estimated by comparing the correlation coefficient (R 2 ) values obtained in various models. Flurbiprofen was dissolved in the polymer solution, and then the THF solvent was evaporated after UV irradiation leaving the drug dispersed in the glassy polymer matrix creating a swelling controlled system. As the solvent (ethanol) penetrates the matrix, the polymer swells and gains the rubbery state. Hence, the drug will be able to diffuse through the matrix. Although diffusion in rubbery systems at equilibrium is generally Fickian, diffusion in a rubbery state which is not at equilibrium may be Fickian or non-Fickian due to the continuous swelling. In sequence, these macromolecular relaxations, and the concentration of ethanol in the polymer matrix, control the release behavior of flurbiprofen.

The drug release of glassy polymers can be express by Korsmeyer-Peppas equation (Eq. 4) . Herein, the mechanisms of drug release are characterized using the release exponent (n value). The diffusion with Fickian is achieved when n = 0.5; when the n value lies in the range 0.5 < n < 1 that indicates an anomalous (non-Fickian) diffusion release model. An n value of 1 corresponds to case II transport, and n > 1 indicates a super case II transport relaxational release [29] . The case II transport represents the flurbiprofen release when ethanol moves with a constant velocity toward the glassy matrix, while in long time of releasing periods, super case II transport mechanism may be achieved for some systems once a continuous swelling behavior of the relaxing polymer occur [30] . In flurbiprofen loaded polyVCi/polyHEMA/polyEGDMA films studied in this work, it has been established that these systems obey zero order release kinetics, which is an important advantage. Zero-order release is the ideal in controlled drug release and has an advantage of delivering drugs at a constant rate. Zero-order has been reported not to be familiar with matrix systems, due to time-dependent changes in drug depleted matrix surface area and diffusional path length [31] . Table 2 shows that the most probable release kinetics for the flurbiprofen loaded films (FB 1 , and FB 2 ) in both periods (PI, and PII), are zero order since a higher "R 2 " values were obtained. The zero-order rate describes systems where drug release rate is independent of its concentration. This mechanism is confirmed by its Ritger-Peppas "n" value (1.00 to 1.42), which indicates super case II release mechanism.

A comparison of the release behavior of flurbiprofen from polyVCi/polyHEMA/polyEGDMA IPN system to other polymethacrylate bearing matrices is illustrated in Table 3 . A summary of the release kinetics parameters of some examples are given in Table 3 . Our IPN system provides a higher loading % of the drug (73.0%) within the synthesized matrix, and more versatile time-controlled release with two periods; the first gives 32% within the first 5 h, and the second one begins at 20 h and it is completed at 35 h, where in the period of 5-20 h, lag time was achieved. No polyVCi/flurbiprofen system could be found in the literature for comparison.

Photoinitiated simultaneous IPN formation in between poly-VCi and polyHEMA in the absence or presence of EGDMA was successfully achieved and optimized. The IPN films are homogenous at the macroscopic level and are transparent film material. However, they exhibit heterogenicity at the microscopic level due to the formation of a dual network. Hydrophilicity of the IPN films increases with increasing amount of polyHEMA in the medium as demonstrated by contact angle measurements and equilibrium swelling capacities in water and in ethanol. The films are thermally stable up to around 300 °C, as revealed by TGA. Successful photo-encapsulation of flurbiprofen into the film matrix was achieved. The IPN films proved to be suitable release matrixes for flurbiprofen demonstrating two stage release behavior. As a result, IPN films are promising devices for a time-controlled release of flurbiprofen. In vitro biocompatibility tests will form the second stage of this study for further biological characterization of the system.

Controlled Drug Delivery. Drug Deliv 1st Ed Burlingt Jones Bartlet Learn

Photocrosslinkable polymers for biomedical applications

Pulsatile drug delivery system: An approach of medication according to circadian rhythm

The modified-release drug delivery landscape: academic viewpoint

Sodium alginate/poly (4-vinylpyridine) polyelectrolyte multilayer films: Preparation, characterization and ciprofloxacin HCl release

Interpenetrating polymer network (IPN): novel approach in drug delivery

Controlled release of bovine serum albumin from stimuli-sensitive silk sericin based interpenetrating polymer network hydrogels

pH-responsive interpenetrating network hydrogel beads of poly (acrylamide)-gcarrageenan and sodium alginate for intestinal targeted drug delivery: Synthesis, in vitro and in vivo evaluation

Smart macroporous IPN hydrogels responsive to pH, temperature, and ionic strength: synthesis, characterization, and evaluation of controlled release of drugs

Photochemically Controlled Drug Dosing from a Polymeric Scaffold

Acrylic acid-methyl methacrylate (2.5: 7.5/2: 8) enteric copolymer for colon targeted drug delivery

The synthesis of poly(vinyl cinnamates) with light-induced shape fixity properties

Nanogels Composed of Cinnamoyl Alginate and Cinnamoyl Pluronic F127

Photolytic and free-radical polymerization of monomethyl maleate esters of epoxidized plant oil triglycerides

Photo-responsive shape-memory and shape-changing liquid-crystal polymer networks

Synthesis, characterization, and studies on the solid-state crosslinking of functionalized vinyl cinnamate polymers

Electrochromic Behaviors of Poly (3-n-octyloxythiophene )

Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)-g-poly (vinylpyrrolidone): Association behavior in aqueous solution and interaction with anionic surfactants

Electro-active nanofibres electrospun from blends of poly-vinyl cinnamate and a cholesteric liquid crystalline silicone polymer

Miscibility of mixed stereoregular PMMA/PVCN monolayers at the air/water interface

Role of nickel oxide nanoparticles on magnetic, thermal and temperature dependent electrical conductivity of novel poly (vinyl cinnamate) based nanocomposites: applicability of different conductivity models

Microdynamics mechanism of D 2 O absorption of the poly(2-hydroxyethyl methacrylate)-based contact lens hydrogel studied by two-dimensional correlation ATR-FTIR spectroscopy

Synthesis and Examination of Nanocomposites Based on Poly(2-hydroxyethyl methacrylate) for Medicinal Use

Nanotechnology-based combinational drug delivery systems for breast cancer treatment

Initiated chemical vapor deposition and light-responsive cross-linking of poly(vinyl cinnamate) thin films

A novel photocrosslinkable polyhedral oligomeric silsesquioxane and its nanocomposites with poly(vinyl cinnamate)

Poly(2-hydroxyethyl methacrylate) (PHEMA) grafted polyethylene/polypropylene (PE/ PP) nonwoven fabric by γ-initiation: Synthesis, characterization and benefits of RAFT mediation

Thermal degradation of poly

Preparation and evaluation of mucin-gelatin mucoadhesive microspheres for rectal delivery of ceftriaxone sodium

Present and future applications of biomaterials in controlled drug delivery systems

The use of a pHdependent and Non pH-dependent natural hydrophobic biopolymer (Landolphia owariensis latex) as capsule coating agents in in vitro controlled release of metronidazole for possible colon targeted delivery

Drug impregnation for laser sintered poly (methyl methacrylate) biocomposites using supercritical carbon dioxide

Photocrosslinkable starch-based polymers for ophthalmologic drug delivery

Synthesis and Characterization of Poly (hydroxyethyl methacrylate-comethacrylic acid) Cross Linked Polymeric Network for the Delivery of Analgesic Agent

The authors gratefully acknowledge the funding of this work by Eastern Mediterranean University (BAP-C-04-18-02).